Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.

Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study. Br J Cancer (1993) 1.08

Erythropoietin: a review. J Natl Med Assoc (1994) 0.87

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Blood (1992) 0.75

Recombinant erythropoietin therapy in renal and nonrenal anemia. West J Med (1992) 0.75

Mutations and prognosis in primary myelofibrosis. Leukemia (2013) 3.13

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Leukemia (2007) 2.61

Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood (1997) 2.31

Efficacy of epirubicin/paclitaxel combination in mobilizing large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen. Haematologica (1999) 2.06

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood (1999) 2.04

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplant (2009) 2.03

Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine (1992) 1.97

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia (2009) 1.80

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia (2008) 1.77

Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. Blood (2000) 1.71

Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol (1995) 1.70

A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol (1988) 1.58

Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant (1998) 1.57

A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol (1998) 1.55

Congenital choledochal cyst: video-guided laparoscopic treatment. Surg Laparosc Endosc (1995) 1.54

Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis. Lancet (1994) 1.52

New tools for clinical evaluation of erythron function in man. Br J Haematol (1992) 1.51

Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. Am J Clin Nutr (2001) 1.50

Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis. Am J Med (2001) 1.49

Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene. Blood (1999) 1.46

Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood (2001) 1.45

Cord blood banking. Vox Sang (2008) 1.41

Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol (2000) 1.41

NEOANEMIA: a knowledge-based system emulating diagnostic reasoning. Comput Biomed Res (1990) 1.41

Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica (2000) 1.41

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Leuk Res (2010) 1.40

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation. Transfusion (2000) 1.39

Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood (1990) 1.39

The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. Haematologica (1999) 1.38

Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. Blood (1990) 1.34

Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol (2012) 1.31

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia. Br J Haematol (1999) 1.29

Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol (1982) 1.27

MPN-associated myelofibrosis (MPN-MF). Leuk Res (2010) 1.25

Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood (1989) 1.25

Changing clinical presentation of multiple myeloma. Eur J Cancer (1991) 1.24

The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody. Br J Haematol (1978) 1.21

Unbalanced X-chromosome inactivation in haemopoietic cells from normal women. Br J Haematol (1998) 1.20

Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica (2001) 1.20

Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood (1996) 1.20

Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol (1995) 1.19

Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood (1998) 1.19

Splenomegalic immunocytoma with circulating hairy cells. Report of eight cases and revision of the literature. Haematologica (1986) 1.19

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol (2001) 1.18

Natural history of idiopathic refractory sideroblastic anemia. Blood (1988) 1.17

Serum albumin in Hodgkin's disease. Cancer (1985) 1.17

Store-dependent Ca(2+) entry in endothelial progenitor cells as a perspective tool to enhance cell-based therapy and adverse tumour vascularization. Curr Med Chem (2012) 1.16

The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood (1999) 1.16

A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol (1995) 1.15

The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis. Haematologica (1999) 1.14

X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation. Proc Natl Acad Sci U S A (1999) 1.12

Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology (2001) 1.09

What are RBC-transfusion-dependence and -independence? Leuk Res (2010) 1.09

Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer (2000) 1.09

The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas. Haematologica (2000) 1.08

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A (1995) 1.08

The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer (1990) 1.07

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol (2003) 1.07

Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion (1993) 1.05

Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood (1998) 1.05

Deciding when to intervene: a Markov decision process approach. Int J Med Inform (2000) 1.04

Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood (1996) 1.04

Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol (1999) 1.04

Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. Br J Haematol (1995) 1.04

Iron metabolism and erythropoiesis after surgery. Br J Surg (1998) 1.01

Primary splenic lymphoma: does it exist? Haematologica (1994) 1.00

Performance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curve. Haematologica (1996) 1.00

Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00

Immunofluorescent detection of factor VIII-related antigen in human platelets and megakaryoctes. Haemostasis (1974) 1.00

A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion (1997) 0.97

Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol (1998) 0.97

Association of acute leukemia and autoimmune polyendocrine syndrome in two kindreds. Leukemia (2003) 0.97

Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity. Br J Haematol (1990) 0.95

Severe pruritus should be a B-symptom in Hodgkin's disease. Cancer (1983) 0.95

Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol (1990) 0.95

A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. Br J Haematol (2001) 0.95

Apoptosis: biological and clinical aspects. Haematologica (2004) 0.94

Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet (1983) 0.94

Waist circumference as a predictor of cardiovascular and metabolic risk factors in obese girls. Eur J Clin Nutr (2003) 0.93

Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res (1988) 0.93

Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol (1983) 0.93

A performance evaluation of the expert system ANEMIA. Comput Biomed Res (1988) 0.93

Hodgkin's disease prognosis: a directly predictive equation. Lancet (1988) 0.93